Search Results for "Regulus Doug Williams"
Matching Channels
None
Matching News
Regulus Appoints Douglas E. Williams, Ph.D. to its Board of Directors
LA JOLLA, Calif., Nov. 7, 2012 /- Regulus Therapeutics Inc . ( NASDAQ: RGLS ), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, anno...
Regulus Therapeutics in an IPO for $80.9 million
Regulus Therapeutics summarized its recent financing activity that the company expects will enable Regulus to execute its current strategic objectives for the foreseeable future. In connection with...
Regulus Therapeutics Inc. (NASDAQ:RGLS) raised $45 million through the sale of 11.3 million shares at $4 in an IPO underwritten by Lazard; Cowen; BMO Capital Markets; Needham; and Wedbush. Regulus als...
Regulus Therapeutics Inc. (San Diego, Calif.) and AstraZeneca plc (LSE:AZN; NYSE:AZN) partnered to develop and commercialize preclinical microRNA therapeutics against three targets focused on cardiova...
Regulus adds Biogen to partner roster
Regulus Therapeutics and Biogen Idec have entered into a collaboration to identify microRNAs as biomarkers for multiple sclerosis. Biogen will invest in Regulus and pay the San Diego-based company u...
San Diego’s Regulus Therapeutics Readies for IPO This Week
San Diego’s Regulus Therapeutics is among eight companies on deck at the Nasdaq exchange for IPOs this week, according to a report today from Renaissance Capital, the Connecticut-based institutional...
Regulus Therapeutics announces IPO for $57.5 million
Regulus Therapeutics capped a busy week of deal-making with a proposed initial public offering of $57.5 million, which the biotech would use in part to fund work on its pipeline of microRNA drugs now...
Regulus, Biogen Idec in microRNA deal
Regulus Therapeutics Inc. (La Jolla, Calif.) partnered with Biogen Idec (NASDAQ:BIIB) to identify microRNA biomarkers in blood from multiple sclerosis patients. Regulus said the biomarkers could be us...
Matching PubMed Articles
We have determined the complete mitochondrial genome (NC_016427) of the Korean red-backed vole, Myodes regulus, which is distributed in South Korea. The total length of the M. regulus mitogenome is 16...
John C. P. Williams of Williams-Beuren syndrome.
John C.P. Williams of New Zealand, whose name is associated with Williams-Beuren syndrome, spent his known professional career primarily in cardiovascular research. His disappearance in the mid-1970s...
Williams-Beuren syndrome: historical aspects.
Williams syndrome, also known as Williams-Beuren syndrome (OMIM database entry 194050), is now known to be commonly associated with a hemizygous chromosomal deletion at 7.q11.23. The way in which the...
